INO has been in the news 900% more than usual
Feb 20, 2026, 7:32 AM
-7.56%
What does INO do
Inovio Pharmaceuticals, based in San Diego, develops DNA medicines targeting infectious diseases, cancer, and HPV-related conditions, with key candidates including INO-3107 for recurrent respiratory papillomatosis. The company employs 122 people and utilizes CELLECTRA devices for DNA delivery.
INO has been in the news recently: The Gross Law Firm, Pomerantz, and The Schall Law Firm have announced or filed class actions against Inovio Pharmaceuticals, Inc. on behalf of investors who bought shares between October 10, 2023 and December 26, 2025.
All three firms say eligible shareholders should register or contact them by the lead plaintiff deadline of April 7, 2026.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.